» Articles » PMID: 24996229

Roles of Ligands from the TNF Superfamily in B Cell Development, Function, and Regulation

Overview
Journal Semin Immunol
Date 2014 Jul 6
PMID 24996229
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Most ligands from the tumour necrosis factor (TNF) superfamily play very important roles in the immune system, and particularly so in B lymphocyte biology. TNF ligands are essential to many aspects of normal B cell biology from development in the bone marrow to maturation in the periphery as well as for activation and differentiation into germinal centre, memory or plasma cells. TNF ligands also influence other aspects of B cell biology such as their ability to present antigens or regulate immune responses. Importantly, inadequate regulation of many TNF ligands is associated with B cell disorders including autoimmunity and cancers. As a result, inhibitors of a number of TNF ligands have been tested in the clinic, with some becoming very successful approved treatments alleviating B cell-mediated pathologies.

Citing Articles

Advances and Challenges in Vaccine Development: Immunological Insights and Future Perspectives.

Miryala K, Swain B Vaccines (Basel). 2025; 13(2).

PMID: 40006748 PMC: 11861604. DOI: 10.3390/vaccines13020202.


Soluble Plasma Proteins of Tumor Necrosis Factor and Immunoglobulin Superfamilies Reveal New Insights into Immune Regulation in People with HIV and Opioid Use Disorder.

Ghanta P, Dang C, Nelson C, Feaster D, Forrest D, Tookes H Vaccines (Basel). 2024; 12(5).

PMID: 38793771 PMC: 11125794. DOI: 10.3390/vaccines12050520.


CDK4 as a Prognostic Marker of Hepatocellular Carcinoma and CDK4 Inhibitors as Potential Therapeutics.

Lai F, Fang Y, Cheng C, Zhong X, Zheng W, Lan S Curr Med Chem. 2024; 32(2):343-358.

PMID: 38231074 PMC: 11826894. DOI: 10.2174/0109298673279399240102095116.


Short-term exposure to fine particulate matter and genome-wide DNA methylation in chronic obstructive pulmonary disease: A panel study conducted in Beijing, China.

Duan R, Niu H, Dong F, Yu T, Li X, Wu H Front Public Health. 2023; 10:1069685.

PMID: 36684947 PMC: 9850166. DOI: 10.3389/fpubh.2022.1069685.


The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody.

Pan Y, Wang S, Liu G, Wang L, Yang L, Zeng X J Med Virol. 2022; 95(1):e28356.

PMID: 36443279 PMC: 9878043. DOI: 10.1002/jmv.28356.